Raynaud's
& Vascular |
Back
to Articles |
| Article Title |
Type |
 |
 |
|
"Pathogenesis
of Vascular Disease in Scleroderma" (Jan.
2007) – posted Feb. 8,
2007
by Richard M. Silver, M.D. |
|
Slides with transcript |
|
"Lipoprotein[a]
and the Lipid Profile in Patients with Systemic
Sclerosis" (2005) – posted
April 18, 2006
by Giuseppe Lippi a,*, Paola Caramaschi
b, Martina Montagnana a,
Gian Luca Salvagno a,
Alessandro Volpe b, Giancesare Guidi
a
aInstituto di Chimica e Microscopia
Clinica, Dipartimento di Scienze Morfologico-Biomediche,
Universita` degli Studi di Verona, Ospedale Policlinico
G.B. Rossi, Piazzale Scuro, 10, 37134 —
Verona, Italy
bDipartimento di Medicina
Clinica, Sezione di Medicina Interna B, Universita`
degli Studi di Verona, Verona, Italy |
|
Article |
|
"Local Hyperhemia
to Heating Is Impaired in Secondary Raynaud's
Phenomenon" (2005) Posted
3/27/2006
by Aude Boignard, Muriel Salvat-Melis, Patrick
H Carpentier, Christopher T Minson, Laurent Grange,
Catherine Duc, Françoise Sarrot-Reynauld,
and Jean-Luc Cracowski |
|
Article |
|
Ask
the Experts about Lupus, Sjögren's Syndrome,
Scleroderma, and Related Conditions From Medscape
Rheumatology: Is bosentan indicated for ulcers
of the finger in SSc? (2005)
Response from Robert I. Fox, M.D., Ph.D., ember,
Rheumatology and Medicine Department, Scripps
Memorial Hospital, La Jolla, California |
|
Q & A |
|
Ask
the Experts about Lupus, Sjögren's Syndrome,
Scleroderma, and Related Conditions From Medscape
Rheumatology: "Scleroderma, Intolerable Finger
Pain, and Progressive Digital Gangrene" (2005)
Response from Robert I. Fox, M.D., Ph.D.,
Member, Rheumatology and Medicine Department,
Scripps Memorial Hospital, La Jolla, California |
|
Q & A |
|
"Systemic
Sclerosis: An Integrated Approach to Understanding,
Recognizing, and Managing Common Vasculopathic
Fibrotic Components" (2004) Posted
March 15, 2006
Chairperson: James R. Seibold, M.D.; Faculty:
Christopher P. Denton, Ph.D., FRCP; Virginia D.
Steen, M.D.; Joseph H. Korn, M.D.; Reviewers:
Brian Katz, M.D.; Janie Leonhardt, M.D.
|
|
Expired CME Activity |
|
"Raynaud
Phenomenon and the Vascular Disease in Scleroderma"
(2004)
M. Bashar Kahaleh, Division of Rheumatology,
Department of Medicine, Medical College of Ohio,
Toledo, Ohio |
|
Article (3 sections) |
|
"Prazosin
for Raynaud's Phenomenon in Progressive Systemic
Sclerosis (2004)
by J Pope; D Fenlon; A Thompson; B Shea; D
Furst; G Wells; A Silman |
|
Abstract |
|
"Digital
Necrosis Related to Carboplatin and Gemcitabine
Therapy in Systemic Sclerosis" (2003)
– Posted April 5, 2006
by Megan E.B. Clowse and Fredrick M. Wigley |
|
Case Report |
|
From
Cochrane Review Abstracts
"Cyclofenil
for Raynaud's Phenomenon in Progressive Systemic
Sclerosis" (1997)
by J Pope; D Fenlon; A Thompson; B Shea; D
Furst; G Wells; A Silman |
|
Abstract |
|
From
Cochrane Review Abstracts
"Ketanserin
for Raynaud's Phenomenon in Progressive Systemic
Sclerosis" (1997)
by J Pope; D Fenlon; A Thompson; B Shea; D
Furst; G Wells; A Silman |
|
Abstract |
|
From
Cochrane Review Abstracts
"Iloprost
and Cisaprost for Raynaud's Phenomenon in Progressive
Systemic Sclerosis" (1997)
by J Pope; D Fenlon; A Thompson; B Shea; D
Furst; G Wells; A Silman |
|
Abstract |
|
|
|
|
|
Back
to Articles
|
 |
|
|
|
|
|
